MAGE-A9B Inhibitors
MAGE-A9B inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the MAGE-A9B protein, a member of the MAGE (Melanoma Antigen Gene) family. The MAGE family is a group of proteins known for their involvement in various cellular processes, including gene regulation, protein-protein interactions, and cellular stress responses. MAGE-A9B, like other MAGE proteins, is thought to play a role in regulating key pathways that influence cellular growth, differentiation, and survival. These proteins are involved in complex molecular interactions, often working as part of larger protein complexes that regulate transcriptional activities or modulate intracellular signaling pathways. By inhibiting MAGE-A9B, researchers can investigate the protein's specific contributions to these processes and its impact on cellular regulation and function.
In research settings, MAGE-A9B inhibitors serve as valuable tools for studying the molecular mechanisms controlled by MAGE-A9B. Inhibiting its activity allows scientists to explore how the disruption of MAGE-A9B affects downstream processes such as gene expression, protein stability, and the regulation of signaling pathways involved in cellular homeostasis. This inhibition provides insights into how MAGE-A9B interacts with other proteins, such as transcription factors or co-regulators, influencing the expression of genes critical for cell growth and differentiation. Additionally, MAGE-A9B inhibitors help researchers understand how the MAGE family proteins as a whole contribute to cellular processes like cell cycle regulation, stress response, and apoptosis. Through these studies, the use of MAGE-A9B inhibitors enhances our understanding of the functional roles of MAGE proteins in cellular physiology, offering deeper insights into the complex molecular networks that govern cellular behavior and gene regulation.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases (HDACs), which can result in altered chromatin structure and gene expression. As HDACs can regulate the expression of MAGE family proteins, this inhibition could suppress MAGE family member A9B activity by altering its gene expression environment. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA inhibits HDACs that are involved in the chromatin remodeling and gene expression regulation, which could reduce the activity of MAGE family member A9B by affecting its interaction with chromatin or its expression control. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin is an HDAC inhibitor that could lower the activity of MAGE family member A9B by changing the chromatin structure and gene expression patterns that influence the activity of MAGE family proteins. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 selectively inhibits class I HDACs. By altering the acetylation status of histones, it could impede the activity of MAGE family member A9B by affecting the transcriptional control of genes involved in its functional pathway. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a potent HDAC inhibitor that can lead to changes in gene expression patterns. This inhibition may impede the functional activity of MAGE family member A9B by affecting the transcriptional networks it is involved in. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat inhibits HDAC activity, which can change gene expression and protein activity. This change may inhibit MAGE family member A9B by affecting the transcriptional networks or chromatin context that regulates its activity. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $62.00 $250.00 $1196.00 | ||
Chidamide is a benzamide HDAC inhibitor that could affect gene expression by altering histone acetylation. Such epigenetic changes could inhibit the activity of MAGE family member A9B by affecting its gene regulatory mechanisms. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid possesses HDAC inhibitory action that could influence gene expression. This could result in the inhibition of MAGE family member A9B by affecting the transcriptional regulation of the protein's activity and interactions. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate acts as an HDAC inhibitor that could alter gene expression and inhibit the activity of MAGE family member A9B by impacting the acetylation status of histones and thus the gene regulatory environment of the protein. | ||||||
(S)-HDAC-42 | 935881-37-1 | sc-296364 sc-296364A | 1 mg 5 mg | $96.00 $417.00 | ||
(S)-HDAC-42 is an HDAC inhibitor that could lead to changes in gene expression and chromatin structure, potentially inhibiting MAGE family member A9B activity by affecting the regulatory mechanisms governing its function. | ||||||